CircRNA fibroblast growth factor receptor 3 promotes tumor progression in non-small cell lung cancer by regulating Galectin-1-AKT/ERK1/2 signaling

J Cell Physiol. 2019 Jul;234(7):11256-11264. doi: 10.1002/jcp.27783. Epub 2018 Nov 22.

Abstract

The dysregulation of circular RNA (circRNA) expression is involved in the progression of several cancers, including non-small cell lung cancer (NSCLC). However, the role and underlying molecular mechanisms of circRNA FGFR3 (circFGFR3) in NSCLC progression remains unknown. Here, we used quantitative real-time polymerase chain reaction to validate that circFGFR3 expression was higher in NSCLC tissues than in the paratumor tissues. Furthermore, our study indicated that the forced circFGFR3 expression promoted NSCLC cell invasion and proliferation. Mechanistically, we found that circFGFR3 promoted NSCLC cell invasion and proliferation via competitively combining with miR-22-3p to facilitate the galectin-1 (Gal-1), p-AKT, and p-ERK1/2 expressions. Clinically, we revealed that the high circFGFR3 expression correlates with the poor clinical outcomes in patients with NSCLC. Together, these data provide mechanistic insights into the circFGFR3-mediated regulation of both the AKT and ERK1/2 signaling pathways by sponging miR-22-3p and increasing Gal-1 expression.

Keywords: circRNA FGFR3 (circFGFR3); circular RNA (circRNA); invasion; micro RNA; non-small cell lung cancer (NSCLC); proliferation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Biomarkers, Tumor / genetics
  • Carcinoma, Non-Small-Cell Lung / genetics
  • Carcinoma, Non-Small-Cell Lung / pathology*
  • Cell Line, Tumor
  • Cell Proliferation / genetics
  • Epithelial-Mesenchymal Transition / genetics
  • Female
  • Galectin 1 / metabolism
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Lung Neoplasms / genetics
  • Lung Neoplasms / pathology*
  • MAP Kinase Signaling System / physiology
  • Male
  • MicroRNAs / genetics*
  • Middle Aged
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Neoplasm Invasiveness / genetics
  • Proto-Oncogene Proteins c-akt / metabolism
  • RNA Interference
  • RNA, Circular / genetics*
  • RNA, Small Interfering / genetics
  • Receptor, Fibroblast Growth Factor, Type 3 / metabolism*
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • Galectin 1
  • LGALS1 protein, human
  • MIRN22 microRNA, human
  • MicroRNAs
  • RNA, Circular
  • RNA, Small Interfering
  • FGFR3 protein, human
  • Receptor, Fibroblast Growth Factor, Type 3
  • Proto-Oncogene Proteins c-akt
  • MAPK3 protein, human
  • Mitogen-Activated Protein Kinase 3